Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/WV/Huntington
Updated July 2026 from ClinicalTrials.gov

Paid Clinical Trials in Huntington, WV

Studies commonly pay $75 to $4,500 per completed study

58 clinical trials are currently recruiting participants within 30 miles of Huntington. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

58studies recruiting
4+research centers nearby
5condition categories
Live from the NIH registry

Studies recruiting near Huntington right now

Top 25 of 58 recruiting studies, sorted by proximity — each links to its official registry page

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Ganglioneuroblastoma, Nodular, Neuroblastoma Phase 3 Interventional 478 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi) · Sponsor: National Cancer Institute (NCI)

A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

Moderately to Severely Active Crohns Disease Phase 3 Interventional 425 participants sought
University Physicians and Surgeons Inc, dba Marshall Health — Huntington, West Virginia (0.8 mi) · Sponsor: Hoffmann-La Roche

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Breast Carcinoma, Colorectal Carcinoma N/A Observational 2,000 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi) · Sponsor: Wake Forest University Health Sciences

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

Castration-Resistant Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8 Phase 2 Interventional 474 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi) · Sponsor: Alliance for Clinical Trials in Oncology

Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder

Opioid Use Disorder, Opioid Use Disorder, Moderate Phase 2 Interventional 310 participants sought
Marshall Health — Huntington, West Virginia (0.8 mi) · Sponsor: T. John Winhusen, PhD

RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT

Neoplasms, Arteriovenous Malformation of Central Nervous System N/A Observational 50,000 participants sought
St. Mary's Medical Center — Huntington, West Virginia (0.8 mi) · Sponsor: The Radiosurgery Society

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Stage I Breast Cancer Phase 3 Interventional 1,670 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi) · Sponsor: NRG Oncology

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Pulmonary Hypertension Due to Lung Diseases and Hypoxia, Pulmonary Hypertension N/A Observational 900 participants sought
Marshall Health — Huntington, West Virginia (0.8 mi) · Sponsor: United Therapeutics

Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors

Breast Cancer, Cognitive Impairments N/A Interventional 386 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi) · Sponsor: NRG Oncology

Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial

Glioblastoma, IDH-Wildtype Phase 2 Interventional 100 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi) · Sponsor: ECOG-ACRIN Cancer Research Group

A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor Phase 2 Interventional 256 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi) · Sponsor: Children's Oncology Group

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Squamous Carcinoma Phase 3 Interventional 1,210 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi) · Sponsor: National Cancer Institute (NCI)

ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 Phase 3 Interventional 1,524 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi) · Sponsor: Alliance for Clinical Trials in Oncology

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi) · Sponsor: SWOG Cancer Research Network

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

Advanced Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8 Phase 3 Interventional 304 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi) · Sponsor: National Cancer Institute (NCI)

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Multiple conditions N/A Observational 2,000 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi) · Sponsor: Alliance for Clinical Trials in Oncology

Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial

Metastatic Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8 Phase 2 Interventional 240 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi) · Sponsor: NRG Oncology

A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)

Non-small Cell Lung Cancer Phase 3 Interventional 868 participants sought
Edwards Comprehensive Cancer Center ( Site 4015) — Huntington, West Virginia (0.8 mi) · Sponsor: Merck Sharp & Dohme LLC

Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old

Migraine Disorders Phase 4 Interventional 132 participants sought
Upsher-Smith Clinical Trial Site #9 — Huntington, West Virginia (0.8 mi) · Sponsor: Upsher-Smith Laboratories

A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis

Primary Biliary Cholangitis (PBC) Phase 3 Interventional 276 participants sought
University Physicians and Surgeons Inc, dba Marshall Health — Huntington, West Virginia (0.8 mi) · Sponsor: Ipsen

Effect of Labetalol, Atenolol, and Nifedipine on Maternal Hemodynamics Measured by ICG in Early Pregnancy

Systolic Hypertension, Pregnancy Related N/A Observational 60 participants sought
Maternal Hypertension Center at Cabell Huntington Hospital — Huntington, West Virginia (0.8 mi) · Sponsor: Marshall University

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma Phase 2 Interventional 40 participants sought
Ohio State University Telemedicine — Huntington, West Virginia (0.8 mi) · Sponsor: Sameek Roychowdhury

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8 Phase 3 Interventional 1,209 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi) · Sponsor: NRG Oncology

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 Phase 3 Interventional 1,875 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi) · Sponsor: National Cancer Institute (NCI)
Google-rated

Top-rated research centers in Huntington

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Health Research Systems

★ 3.5
7 Stonecrest Dr, Huntington, WV 25701
(304) 529-4453
"Had a great experience getting a drug screening at Health Research Systems in Huntington, WV. The staff was courteous, efficient, and kept everything…"
— Gabriels Travel Secrets, 5★

Marshall University Joan C. Edwards School of Medicine

★ 4.8
1600 Medical Center Dr, Huntington, WV 25701
(304) 691-1700
"Wonderful campus, friendly staff, and delightful students"
— Sunny “SUNNY” Sturgell- Morris, 5★

Marshall Health

★ 2.3
1600 Medical Center Dr, Huntington, WV 25701
(304) 691-1600

CAMC Clinical Trials Center

★ 5.0
3100 MacCorkle Ave SE #806, Charleston, WV 25304
(304) 388-9944

Clinical trials in Huntington: what's recruiting

The Huntington area currently has 58 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Huntington, the most active research areas are:

  • Cancer & Oncology17 studies
  • Liver & Kidney3 studies
  • Heart & Vascular2 studies
  • Immune & Skin1 studies
  • Lungs & Breathing1 studies

Every listing shows the study phase, the recruiting site and its distance from Huntington, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Huntington

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Huntington participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Huntington pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Do I need to be sick to join a clinical trial in Huntington?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Huntington safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How often do new paid studies open in Huntington?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Huntington.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Huntington typically complete one or two studies per year.

Paid clinical trials near Huntington

Other metros within reach

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

Get free trial alerts